查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813504

肌萎縮側索硬化症 (ALS) 市場分析及預測（至 2034 年）：類型、產品、服務、技術、組件、應用、設備、流程和最終用戶

Amyotrophic Lateral Sclerosis Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Device, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 304 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

肌萎縮側索硬化症 (ALS) 市場預計將從 2024 年的 12 億美元增至 2034 年的 21 億美元，複合年成長率約為 5.8%。肌萎縮側索硬化症 (ALS) 市場涵蓋用於治療 ALS（一種進行性神經退化性疾病）的藥物、診斷產品和支持性治療。基因治療、新藥研發和科研經費的不斷增加推動了該市場的發展。認知度的提高和診斷技術的進步正在推動對創新療法的需求。專注於延長患者生命和改善患者生活品質的策略合作和監管支援正在進一步推動市場成長。

肌萎縮側索硬化症 (ALS) 市場正經歷著蓬勃發展，這得益於治療方案的進步和診斷創新。治療領域佔首位，主要得益於疾病修正治療療法和對症療法。創新藥物配方和新型治療層級正在推動該領域的擴張。診斷領域表現第二佳，主要得益於生物標記技術和基因檢測的顯著進步。這些技術創新正在增強早期診斷和個人化治療的方法。研發活動正在加強，尤其是在神經保護劑和再生醫學領域。新型生物技術和基因療法正日益受到關注，預計將改變 ALS 治療的模式。人工智慧在藥物研發和病患管理的應用進一步提升了成長前景。製藥公司和研究機構之間的合作正在促進創新，並加速有效解決方案的開發。人們對 ALS 的認知和倡導日益增強，也推動了對先進醫療解決方案的需求不斷成長。

市場區隔
類型 散發性 ALS、遺傳性ALS
產品 Riluzole、Edaravone、替拉西酮、nuedexta、馬賽替尼
服務 病患支援服務、諮詢服務與臨床試驗服務
科技 生物技術、藥物基因體學、基因治療、幹細胞治療
成分 原料藥、輔料
目的 醫院、門診手術中心及研究機構
裝置 非侵入性通氣、經皮視鏡胃造口術
流程 藥物開發、臨床試驗、核准和商業化
最終用戶 醫療保健提供者、患者和製藥公司

市場概述

肌萎縮側索硬化症 (ALS) 市場正在發生動態變化，主要企業佔據了顯著的市場佔有率。定價策略正隨著競爭壓力和病患需求而不斷發展，創新定價模式也不斷湧現。生物技術的進步和對疾病機制的深入了解正在推動市場推出新產品。這些發展正在增加治療選擇、改善患者預後並塑造競爭格​​局。競爭基準基準化分析揭示了主要企業之間的激烈競爭，而策略夥伴關係和聯盟正在塑造市場動態。北美和歐洲的監管機構正在實施嚴格的指導方針，影響市場進入和擴大策略。 ALS 市場的特點是研發投入高，重點是新療法和個人化醫療。此外，專利到期和學名藥的進入進一步使競爭格局複雜化，預計這將改變競爭平衡並推動市場發展。

主要趨勢和促進因素

在研發和治療方法方法不斷進步的推動下，肌萎縮側索硬化症 (ALS) 市場不斷發展。神經病學研究資金的增加促進了創新治療方法的發現。新藥核准和臨床試驗正在擴大治療方法選擇，以解決 ALS 治療中未滿足的醫療需求。個人化醫療的興起是一個關鍵趨勢，基因檢測可以根據個別患者情況進行標靶治療。這種方法提高了治療效果和患者預後。製藥公司和研究機構之間的合作正在加快技術創新的步伐。包括遠端醫療和遠端監控在內的數位健康技術正在改變患者管理並提高醫療服務的可及性。這些技術促進了即時數據收集，增強了疾病追蹤和干涉策略。對孤兒藥開發的監管支持和激勵措施正在創造有利於市場成長的環境。隨著相關人員利用這些趨勢推動診斷、治療和患者照護的進步，ALS 市場將迎來擴張。

阻礙因素與挑戰：

肌萎縮側索硬化症 (ALS) 市場面臨多種市場限制和挑戰。一個主要阻礙因素是藥物開發和臨床試驗的高成本。這種經濟負擔限制了新進入者並減緩了創新的步伐。此外，ALS 是一種罕見疾病，限制了符合臨床試驗條件的患者數量，使患者招募過程複雜化並延長了時間。另一個挑戰是缺乏明確的診斷測試。這會導致診斷和治療開始的延遲，影響患者的預後。 ALS 的複雜病理也阻礙了有效治療方法的發展。研究人員難以理解該疾病的潛在機制。此外，監管障礙和新療法的嚴格核准程序延誤了市場進入。醫療專業人員和公眾也非常需要意識提升和教育。這些知識差距可能會阻礙早期診斷和早期療育，影響整體市場成長。

關鍵人物

BrainStorm Cell Therapeutics、田邊三菱製藥株式會社、Orphazyme、AB Science、MediciNova、Biogen、Ionis Pharmaceuticals、Cytokinetics、Amylyx Pharmaceuticals、Apellis Pharmaceuticals、Anelixis Therapeutics、Treeharmway、Genervon Biopaceutical

目錄

第 1 章。肌萎縮側索硬化症市場概述

  • 調查目的
  • 肌萎縮側索硬化症市場定義與研究範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

第4章肌萎縮側索硬化症市場展望

  • 肌萎縮側索硬化症市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章肌萎縮側索硬化症市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買興趣
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章肌萎縮側索硬化症市場規模

  • 肌萎縮側索硬化症市場規模（以價值計算）
  • 肌萎縮側索硬化症市場規模

7. 肌萎縮側索硬化症市場（按類型）

  • 市場概況
  • 散發性 ALS
  • 遺傳性肌萎縮性側索硬化症
  • 其他

8. 肌萎縮側索硬化症市場（按產品）

  • 市場概況
  • Riluzole
  • Edaravone
  • 奇拉塞米替布
  • Nuedexta
  • 馬賽替尼
  • 其他

9. 肌萎縮側索硬化症市場（依服務）

  • 市場概況
  • 病人支援服務
  • 諮詢服務
  • 臨床試驗服務
  • 其他

10. 肌萎縮側索硬化症市場（按技術）

  • 市場概況
  • 生物技術
  • 藥物基因體學
  • 基因治療
  • 幹細胞療法
  • 其他

11. 肌萎縮側索硬化症市場（依成分）

  • 市場概況
  • 原料藥
  • 輔料
  • 其他

第 12 章肌萎縮側索硬化症市場（按應用）

  • 市場概況
  • 醫院
  • 門診手術中心
  • 研究所
  • 其他

13. 肌萎縮側索硬化症市場（按設備）

  • 市場概況
  • 非侵入性通氣
  • 經皮視鏡胃造口術
  • 其他

第 14 章。肌萎縮側索硬化症市場（按過程）

  • 市場概況
  • 藥物開發
  • 臨床試驗
  • 藥品核准
  • 商業化
  • 其他

第 15 章。肌萎縮側索硬化症市場（依最終用戶）

  • 市場概況
  • 醫療保健提供者
  • 病人
  • 製藥公司
  • 其他

16. 肌萎縮側索硬化症市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第17章競爭格局

  • 概述
  • 市佔率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第18章：公司簡介

  • BrainStorm Cell Therapeutics
  • Mitsubishi Tanabe Pharma Corporation
  • Orphazyme
  • AB Science
  • MediciNova
  • Biogen
  • Ionis Pharmaceuticals
  • Cytokinetics
  • Amylyx Pharmaceuticals
  • Apellis Pharmaceuticals
  • Anelixis Therapeutics
  • Treeway
  • Genervon Biopharmaceuticals
  • NeuroSense Therapeutics
  • QurAlis
簡介目錄
Product Code: GIS33612

Amyotrophic Lateral Sclerosis Market is anticipated to expand from $1.2 billion in 2024 to $2.1 billion by 2034, growing at a CAGR of approximately 5.8%. The Amyotrophic Lateral Sclerosis (ALS) Market encompasses pharmaceuticals, diagnostics, and supportive care aimed at managing ALS, a progressive neurodegenerative disorder. The market is driven by advancements in gene therapy, novel drug development, and increased research funding. Rising awareness and improved diagnostic techniques are propelling demand for innovative treatments. Strategic collaborations and regulatory support further enhance market growth, focusing on extending patient lifespans and improving quality of life.

The Amyotrophic Lateral Sclerosis (ALS) Market is experiencing dynamic growth, propelled by advancements in therapeutic options and diagnostic innovations. The therapeutics segment is the top performer, with disease-modifying therapies and symptomatic treatments leading the charge. Innovative drug formulations and novel therapeutic classes are driving this segment's expansion. The diagnostics segment follows as the second highest performer, with significant advancements in biomarker technologies and genetic testing. These innovations are enhancing early diagnosis and personalized treatment approaches. Research and development activities are intensifying, focusing on neuroprotective agents and regenerative medicine. Emerging biotechnologies and gene therapies are capturing attention, promising to revolutionize ALS treatment paradigms. The integration of artificial intelligence in drug discovery and patient management is further augmenting growth prospects. Collaborations between pharmaceutical companies and research institutions are fostering innovation, accelerating the development of effective solutions. The increasing awareness and advocacy for ALS are also contributing to heightened demand for advanced healthcare solutions.

Market Segmentation
TypeSporadic ALS, Familial ALS
ProductRiluzole, Edaravone, Tirasemtiv, Nuedexta, Masitinib
ServicesPatient Support Services, Consultation Services, Clinical Trial Services
TechnologyBiotechnology, Pharmacogenomics, Gene Therapy, Stem Cell Therapy
ComponentActive Pharmaceutical Ingredients, Excipients
ApplicationHospitals, Ambulatory Surgical Centers, Research Institutes
DeviceNon-Invasive Ventilation, Percutaneous Endoscopic Gastrostomy
ProcessDrug Development, Clinical Trials, Regulatory Approval, Commercialization
End UserHealthcare Providers, Patients, Pharmaceutical Companies

Market Snapshot:

The Amyotrophic Lateral Sclerosis (ALS) market is witnessing dynamic shifts with significant market share held by leading pharmaceutical companies. Pricing strategies are evolving in response to competitive pressures and patient needs, with innovative pricing models emerging. New product launches are invigorating the market, driven by advancements in biotechnology and a deeper understanding of disease mechanisms. These developments are enhancing treatment options and improving patient outcomes, fostering a competitive landscape. Competition benchmarking reveals a robust rivalry among key players, with strategic partnerships and collaborations shaping the market dynamics. Regulatory influences are pivotal, as agencies in North America and Europe impose stringent guidelines, impacting market entry and expansion strategies. The ALS market is characterized by high R&D investments, focusing on novel therapeutics and personalized medicine. The landscape is further complicated by patent expirations and generic drug entries, which are expected to alter the competitive equilibrium and drive market evolution.

Geographical Overview:

The Amyotrophic Lateral Sclerosis (ALS) market is witnessing varied growth patterns across different regions. North America remains at the forefront, driven by advanced healthcare infrastructure and significant research investments. The presence of leading pharmaceutical companies and robust funding for ALS research further bolster market expansion. Europe follows, with increased awareness and government initiatives supporting ALS treatment advancements. Asia Pacific is emerging as a promising growth pocket, propelled by rising healthcare expenditure and expanding patient awareness. Countries like China and Japan are at the helm, investing heavily in research and development. Meanwhile, Latin America and the Middle East & Africa are gradually gaining momentum. These regions are recognizing the need for improved healthcare frameworks and are beginning to channel resources towards ALS treatment and research. Brazil and South Africa are notable emerging players, showing potential for substantial market growth in the coming years.

Key Trends and Drivers:

The Amyotrophic Lateral Sclerosis (ALS) market is evolving, driven by advancements in research and therapeutic development. Increased funding for neurological research is propelling the discovery of innovative treatment modalities. New drug approvals and clinical trials are expanding therapeutic options, addressing unmet medical needs in ALS care. The rise of personalized medicine is a key trend, with genetic testing enabling targeted therapies tailored to individual patient profiles. This approach enhances treatment efficacy and patient outcomes. Collaborations between pharmaceutical companies and research institutions are accelerating the pace of innovation. Digital health technologies, including telemedicine and remote monitoring, are transforming patient management, improving accessibility to care. These technologies facilitate real-time data collection, enhancing disease tracking and intervention strategies. Regulatory support and incentives for orphan drug development are fostering a conducive environment for market growth. The ALS market is poised for expansion as stakeholders capitalize on these trends, driving progress in diagnosis, treatment, and patient care.

Restraints and Challenges:

The Amyotrophic Lateral Sclerosis (ALS) market encounters several substantial restraints and challenges. A significant restraint is the high cost of drug development and clinical trials. This financial burden limits the entry of new players and slows the pace of innovation. Additionally, the rarity of ALS results in a limited patient pool for clinical studies, which complicates the recruitment process and extends timelines. Another challenge is the lack of definitive diagnostic tests. This results in delayed diagnosis and treatment initiation, affecting patient outcomes. The complexity of ALS pathology also hinders the development of effective therapies. Researchers face difficulties in understanding the disease's underlying mechanisms. Furthermore, regulatory hurdles and stringent approval processes for new treatments can delay market entry. There is also a significant need for increased awareness and education among healthcare professionals and the public. This gap in knowledge can impede early diagnosis and intervention, affecting overall market growth.

Key Players:

BrainStorm Cell Therapeutics, Mitsubishi Tanabe Pharma Corporation, Orphazyme, AB Science, MediciNova, Biogen, Ionis Pharmaceuticals, Cytokinetics, Amylyx Pharmaceuticals, Apellis Pharmaceuticals, Anelixis Therapeutics, Treeway, Genervon Biopharmaceuticals, NeuroSense Therapeutics, QurAlis

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Amyotrophic Lateral Sclerosis Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Amyotrophic Lateral Sclerosis Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Device
  • 2.10 Key Highlights of the Market, by Process
  • 2.11 Key Highlights of the Market, by End User
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Device
  • 3.9 Market Attractiveness Analysis, by Process
  • 3.10 Market Attractiveness Analysis, by End User
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Amyotrophic Lateral Sclerosis Market Outlook

  • 4.1 Amyotrophic Lateral Sclerosis Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Amyotrophic Lateral Sclerosis Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Amyotrophic Lateral Sclerosis Market Size

  • 6.1 Amyotrophic Lateral Sclerosis Market Size, by Value
  • 6.2 Amyotrophic Lateral Sclerosis Market Size, by Volume

7: Amyotrophic Lateral Sclerosis Market, by Type

  • 7.1 Market Overview
  • 7.2 Sporadic ALS
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Familial ALS
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Amyotrophic Lateral Sclerosis Market, by Product

  • 8.1 Market Overview
  • 8.2 Riluzole
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Edaravone
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Tirasemtiv
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Nuedexta
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Masitinib
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Others
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region

9: Amyotrophic Lateral Sclerosis Market, by Services

  • 9.1 Market Overview
  • 9.2 Patient Support Services
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Consultation Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Clinical Trial Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Amyotrophic Lateral Sclerosis Market, by Technology

  • 10.1 Market Overview
  • 10.2 Biotechnology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Pharmacogenomics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Gene Therapy
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Stem Cell Therapy
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Amyotrophic Lateral Sclerosis Market, by Component

  • 11.1 Market Overview
  • 11.2 Active Pharmaceutical Ingredients
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Excipients
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Others
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region

12: Amyotrophic Lateral Sclerosis Market, by Application

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Ambulatory Surgical Centers
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Amyotrophic Lateral Sclerosis Market, by Device

  • 13.1 Market Overview
  • 13.2 Non-Invasive Ventilation
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Percutaneous Endoscopic Gastrostomy
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Amyotrophic Lateral Sclerosis Market, by Process

  • 14.1 Market Overview
  • 14.2 Drug Development
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical Trials
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Regulatory Approval
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Commercialization
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Amyotrophic Lateral Sclerosis Market, by End User

  • 15.1 Market Overview
  • 15.2 Healthcare Providers
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Patients
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Pharmaceutical Companies
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Amyotrophic Lateral Sclerosis Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Component
    • 16.2.7 North America Market Size and Forecast, by Application
    • 16.2.8 North America Market Size and Forecast, by Device
    • 16.2.9 North America Market Size and Forecast, by Process
    • 16.2.10 North America Market Size and Forecast, by End User
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Component
      • 16.2.9.6 United States Market Size and Forecast, by Application
      • 16.2.9.7 United States Market Size and Forecast, by Device
      • 16.2.9.8 United States Market Size and Forecast, by Process
      • 16.2.9.9 United States Market Size and Forecast, by End User
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Component
      • 16.2.10.6 Canada Market Size and Forecast, by Application
      • 16.2.10.7 Canada Market Size and Forecast, by Device
      • 16.2.10.8 Canada Market Size and Forecast, by Process
      • 16.2.10.9 Canada Market Size and Forecast, by End User
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Component
    • 16.3.7 Europe Market Size and Forecast, by Application
    • 16.3.8 Europe Market Size and Forecast, by Device
    • 16.3.9 Europe Market Size and Forecast, by Process
    • 16.3.10 Europe Market Size and Forecast, by End User
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.9 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Component
      • 16.3.10.6 Germany Market Size and Forecast, by Application
      • 16.3.10.7 Germany Market Size and Forecast, by Device
      • 16.3.10.8 Germany Market Size and Forecast, by Process
      • 16.3.10.9 Germany Market Size and Forecast, by End User
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Component
      • 16.3.11.6 France Market Size and Forecast, by Application
      • 16.3.11.7 France Market Size and Forecast, by Device
      • 16.3.11.8 France Market Size and Forecast, by Process
      • 16.3.11.9 France Market Size and Forecast, by End User
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Component
      • 16.3.12.6 Spain Market Size and Forecast, by Application
      • 16.3.12.7 Spain Market Size and Forecast, by Device
      • 16.3.12.8 Spain Market Size and Forecast, by Process
      • 16.3.12.9 Spain Market Size and Forecast, by End User
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Component
      • 16.3.13.6 Italy Market Size and Forecast, by Application
      • 16.3.13.7 Italy Market Size and Forecast, by Device
      • 16.3.13.8 Italy Market Size and Forecast, by Process
      • 16.3.13.9 Italy Market Size and Forecast, by End User
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Component
      • 16.3.14.6 Netherlands Market Size and Forecast, by Application
      • 16.3.14.7 Netherlands Market Size and Forecast, by Device
      • 16.3.14.8 Netherlands Market Size and Forecast, by Process
      • 16.3.14.9 Netherlands Market Size and Forecast, by End User
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Component
      • 16.3.15.6 Sweden Market Size and Forecast, by Application
      • 16.3.15.7 Sweden Market Size and Forecast, by Device
      • 16.3.15.8 Sweden Market Size and Forecast, by Process
      • 16.3.15.9 Sweden Market Size and Forecast, by End User
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Component
      • 16.3.16.6 Switzerland Market Size and Forecast, by Application
      • 16.3.16.7 Switzerland Market Size and Forecast, by Device
      • 16.3.16.8 Switzerland Market Size and Forecast, by Process
      • 16.3.16.9 Switzerland Market Size and Forecast, by End User
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Component
      • 16.3.17.6 Denmark Market Size and Forecast, by Application
      • 16.3.17.7 Denmark Market Size and Forecast, by Device
      • 16.3.17.8 Denmark Market Size and Forecast, by Process
      • 16.3.17.9 Denmark Market Size and Forecast, by End User
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Component
      • 16.3.18.6 Finland Market Size and Forecast, by Application
      • 16.3.18.7 Finland Market Size and Forecast, by Device
      • 16.3.18.8 Finland Market Size and Forecast, by Process
      • 16.3.18.9 Finland Market Size and Forecast, by End User
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Component
      • 16.3.19.6 Russia Market Size and Forecast, by Application
      • 16.3.19.7 Russia Market Size and Forecast, by Device
      • 16.3.19.8 Russia Market Size and Forecast, by Process
      • 16.3.19.9 Russia Market Size and Forecast, by End User
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.10 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Component
      • 16.4.9.6 China Market Size and Forecast, by Application
      • 16.4.9.7 China Market Size and Forecast, by Device
      • 16.4.9.8 China Market Size and Forecast, by Process
      • 16.4.9.9 China Market Size and Forecast, by End User
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Component
      • 16.4.10.6 India Market Size and Forecast, by Application
      • 16.4.10.7 India Market Size and Forecast, by Device
      • 16.4.10.8 India Market Size and Forecast, by Process
      • 16.4.10.9 India Market Size and Forecast, by End User
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Component
      • 16.4.11.6 Japan Market Size and Forecast, by Application
      • 16.4.11.7 Japan Market Size and Forecast, by Device
      • 16.4.11.8 Japan Market Size and Forecast, by Process
      • 16.4.11.9 Japan Market Size and Forecast, by End User
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Component
      • 16.4.12.6 South Korea Market Size and Forecast, by Application
      • 16.4.12.7 South Korea Market Size and Forecast, by Device
      • 16.4.12.8 South Korea Market Size and Forecast, by Process
      • 16.4.12.9 South Korea Market Size and Forecast, by End User
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Component
      • 16.4.13.6 Australia Market Size and Forecast, by Application
      • 16.4.13.7 Australia Market Size and Forecast, by Device
      • 16.4.13.8 Australia Market Size and Forecast, by Process
      • 16.4.13.9 Australia Market Size and Forecast, by End User
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Component
      • 16.4.14.6 Singapore Market Size and Forecast, by Application
      • 16.4.14.7 Singapore Market Size and Forecast, by Device
      • 16.4.14.8 Singapore Market Size and Forecast, by Process
      • 16.4.14.9 Singapore Market Size and Forecast, by End User
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Component
      • 16.4.15.6 Indonesia Market Size and Forecast, by Application
      • 16.4.15.7 Indonesia Market Size and Forecast, by Device
      • 16.4.15.8 Indonesia Market Size and Forecast, by Process
      • 16.4.15.9 Indonesia Market Size and Forecast, by End User
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Component
      • 16.4.16.6 Taiwan Market Size and Forecast, by Application
      • 16.4.16.7 Taiwan Market Size and Forecast, by Device
      • 16.4.16.8 Taiwan Market Size and Forecast, by Process
      • 16.4.16.9 Taiwan Market Size and Forecast, by End User
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Component
      • 16.4.17.6 Malaysia Market Size and Forecast, by Application
      • 16.4.17.7 Malaysia Market Size and Forecast, by Device
      • 16.4.17.8 Malaysia Market Size and Forecast, by Process
      • 16.4.17.9 Malaysia Market Size and Forecast, by End User
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Component
    • 16.5.7 Latin America Market Size and Forecast, by Application
    • 16.5.8 Latin America Market Size and Forecast, by Device
    • 16.5.9 Latin America Market Size and Forecast, by Process
    • 16.5.10 Latin America Market Size and Forecast, by End User
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Component
      • 16.5.9.6 Brazil Market Size and Forecast, by Application
      • 16.5.9.7 Brazil Market Size and Forecast, by Device
      • 16.5.9.8 Brazil Market Size and Forecast, by Process
      • 16.5.9.9 Brazil Market Size and Forecast, by End User
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Component
      • 16.5.10.6 Mexico Market Size and Forecast, by Application
      • 16.5.10.7 Mexico Market Size and Forecast, by Device
      • 16.5.10.8 Mexico Market Size and Forecast, by Process
      • 16.5.10.9 Mexico Market Size and Forecast, by End User
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Component
      • 16.5.11.6 Argentina Market Size and Forecast, by Application
      • 16.5.11.7 Argentina Market Size and Forecast, by Device
      • 16.5.11.8 Argentina Market Size and Forecast, by Process
      • 16.5.11.9 Argentina Market Size and Forecast, by End User
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.10 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Component
      • 16.6.10.6 UAE Market Size and Forecast, by Application
      • 16.6.10.7 UAE Market Size and Forecast, by Device
      • 16.6.10.8 UAE Market Size and Forecast, by Process
      • 16.6.10.9 UAE Market Size and Forecast, by End User
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Component
      • 16.6.11.6 South Africa Market Size and Forecast, by Application
      • 16.6.11.7 South Africa Market Size and Forecast, by Device
      • 16.6.11.8 South Africa Market Size and Forecast, by Process
      • 16.6.11.9 South Africa Market Size and Forecast, by End User
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 BrainStorm Cell Therapeutics
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Mitsubishi Tanabe Pharma Corporation
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Orphazyme
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 AB Science
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 MediciNova
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Biogen
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Ionis Pharmaceuticals
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Cytokinetics
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Amylyx Pharmaceuticals
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Apellis Pharmaceuticals
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Anelixis Therapeutics
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Treeway
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Genervon Biopharmaceuticals
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 NeuroSense Therapeutics
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 QurAlis
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis